Immunoscintigraphy in the follow-up of patients operated on for carcinoma of the sigmoid and rectum

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Diseases of the Colon & Rectum

• Publication date

  1987-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/BF02561688PMID 3304885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Immunoscintigraphy of colon carcinoma.

  1984cited by this paper
• Improved radioimaging and tumor localization with monoclonal F(ab')2.

  1983cited by this paper
• Radioimmunodetection of primary and metastatic ovarian cancer using radiolabeled antibodies to carcinoembryonic antigen.

  1980cited by this paper
• Use of radiolabeled antibodies to carcinoembryonic antigen for the detection and localization of diverse cancers by external photoscanning.

  1978cited by this paper

• Generation and Characterization of a Recombinant/Chimeric B72.3 (Human 7^

  2006cites this paper
• Nonantigen-Specific Tissue Localization of Monoclonal Antibodies

  2006cites this paper
• High-affinity chimeric anti-(colorectal carcinoma) antibody correlated to enhanced tumor targeting in biodistribution and imaging

  2005cites this paper
• Comparative biological properties of a recombinant chimeric anti-carcinoma mAb and a recombinant aglycosylated variant

  2005cites this paper
• Clinical experience with radiolabelled monoclonal antibodies in the detection of colorectal and ovarian carcinoma recurrence and review of the literature.

  1999cites this paper
• In Vivo Comparison of CHX-DTPA Ligand Isomers in Athymic Mice Bearing Carcinoma Xenografts

  1999cites this paper
• Radioimmunoguided surgery of colorectal carcinoma with an 111In-labelled anti-TAG72 monoclonal antibody.

  1999cites this paper
• In vivo evaluation of a lead-labeled monoclonal antibody using the DOTA ligand

  1998cites this paper
• Radioimmunoguided surgery in colorectal cancer: a 6-year experience with four different technical solutions.

  1998cites this paper
• Analysis of specific accumulation of radiolabeled anti-carcinoembryonic antigen monoclonal antibody CEA 102 in colorectal cancer using computed radiography.

  1997cites this paper
• Radioimmunoscintigraphy of Gastric Adenocarcinomas with 99mTc-Chimeric ccM4 Antibody

  1996cites this paper
• Selection of a peptide with affinity for the tumor-associated TAG72 antigen from a phage-displayed library.

  1996cites this paper
• Identification of a decapeptide with the binding reactivity for tumor‐associated TAG72 antigen from a phage displayed library

  1996cites this paper
• Establishment of a rat colonic carcinoma model for study of immunoreagents against the human tumor-associated TAG72 antigen.

  1996cites this paper
• Establishment of a Rat Colonie Carcinoma Model for Study of Immunoreagents against the Human TumorAssociated TAG72 Antigen

  1996cites this paper
• Radioimmunotherapy for Pancreatic Carcinoma Using 131I‐Labeled Monoclonal Antibody Nd2 in Xenografted Nude Mice

  1996cites this paper
• Tumor markers as targets for selective diagnostic and therapeutic procedures.

  1996cites this paper
• Comparison of iodine-123-vasoactive intestinal peptide receptor scintigraphy and indium-111-CYT-103 immunoscintigraphy.

  1996cites this paper
• Genetically Engineered Antitumor Monoclonal Antibodies

  1995cites this paper
• Autoradiographic evaluation of radiolabeled monoclonal antibody B72.3 distribution in tumor and lymph nodes of adenocarcinoma patients.

  1995cites this paper
• The role of tumor rejection antigens in host antitumor defense mechanisms

  1995cites this paper
• Radiolabeled antibody imaging of patients with potentially resectable colorectal adenocarcinoma.

  1994cites this paper
• A Heavy-Chain Grafted Antibody that Recognizes the Tumor-Associated TAG72 Antigen

  1994cites this paper
• Cloning and Expression of Functional cDNA Genes of a Mouse/Human Chimeric Antibody rcM4

  1994cites this paper
• Production of a bifunctional hybrid molecule B72.3/metallothionein-1 by protein engineering.

  1993cites this paper
• Clinical applications of indium-111-labeled monoclonal antibody imaging in colorectal cancer patients.

  1993cites this paper
• High Binding Affinity Chimeric Anti-Colorectal Carcinoma Antibody Correlated to Enhanced Tumor Binding and Effector Function

  1993cites this paper
• Use of the radiolabeled murine monoclonal antibody, 111In-CYT-103, in the management of colon cancer.

  1993cites this paper
• Preferential use of a H chain V region in antitumor-associated glycoprotein-72 monoclonal antibodies.

  1993cites this paper
• Role of In‐111 Labeled CYT‐103 Immunoscintigraphy in the Evaluation of Patients With Recurrent Colorectal Carcinoma

  1993cites this paper
• Radioimmunodetection of colorectal cancer metastases with 131I-labeled monoclonal antibody B72.3: a pilot study to determine efficacy of detection and pharmacokinetics.

  1993cites this paper
• Construction and Purification of Domain-Deleted Immunoglobulin Variants of the Recombinant/Chimeric B72.3 (y1) Monoclonal Antibody

  1993cites this paper
• A model for others: a strategy for improving diagnosis and therapy of human malignancies using monoclonal antibodies targeting TAG-72 oncofetal antigen.

  1993cites this paper
• Biologic properties of a Ch2 domain‐deleted recombinant immunoglobulin

  1993cites this paper
• Genetic engineering of anticolorectal carcinoma Fv molecule in myeloma cells.

  1992cites this paper
• Immunoscintigraphy performed with In-111-labeled CYT-103 in the management of colorectal cancer: comparison with CT.

  1992cites this paper
• Autoradiographic Analysis of Radiolabeled Anti‐carcinoembryonic Antigen Monoclonal Antibody CEA102 in Colorectal Cancer Using Computed Radiography

  1992cites this paper
• Construction and characterization of a high-affinity chimeric anti-colorectal carcinoma antibody ccM4.

  1992cites this paper
• New diagnostic imaging in rectal cancer: Endosonography and immunoscintigraphy

  1992cites this paper
• Genetic engineering of high affinity anti-human colorectal tumour mouse/human chimeric antibody.

  1992cites this paper
• Production of hybrid bispecific antibody recognizing human colorectal carcinoma and CD3 antigen.

  1992cites this paper
• 99mTc-IMMU-4 monoclonal antibody scan in colorectal cancer. A prospective study.

  1992cites this paper
• Monoclonal antibodies in the management of carcinoma patients

  1991cites this paper
• Radiolabeled Antibody Imaging in the Management of Colorectal Cancer Results of a Multicenter Clinical Study

  1991cites this paper
• Radioimmunoguided surgery using iodine 125 B72.3 in patients with colorectal cancer.

  1991cites this paper
• Radioimmunolocalization of pelvic recurrences from rectosigmoid cancer employing 111In anti-CEA F(ab')2.

  1991cites this paper
• Generation and characterization of a recombinant/chimeric B72.3 (human gamma 1).

  1991cites this paper
• Regional heterogeneity and complementation in the expression of the tumor-associated glycoprotein 72 epitopes in colorectal cancer.

  1991cites this paper
• Monoclonal antibodies in imaging and therapy of colorectal cancer

  1991cites this paper
• Serum TAG 72 levels in different human carcinomas.

  1991cites this paper
• Potential for Artifacts in Monitoring for the Detection of Tumor Associated Antigens (TAG-72 and CEA) in Serum from Patients Undergoing MAb-based Diagnostic and Therapeutic Protocols

  1990cites this paper
• Advantage of dose fractionation in monoclonal antibody-targeted radioimmunotherapy.

  1990cites this paper
• Production of murine V-human Cr1 chimeric anti-TAG72 antibody using V region cDNA amplified by PCR.

  1990cites this paper
• Clinical radioimmunodetection, 1978-1988: overview and suggestions for standardization of clinical trials.

  1990cites this paper
• Enhanced tumor binding using immunohistochemical analyses by second generation anti-tumor-associated glycoprotein 72 monoclonal antibodies versus monoclonal antibody B72.3 in human tissue.

  1990cites this paper
• In vivo fate of monoclonal antibody B72.3 in patients with colorectal cancer.

  1990cites this paper
• Nonspecific uptake in radioimmunoscintigraphy.

  1990cites this paper
• Assay for the detection of anti‐idiotypic antibodies to monoclonal antibody b72.3

  1990cites this paper
• Ultrasmall superparamagnetic iron oxide: an intravenous contrast agent for assessing lymph nodes with MR imaging.

  1990cites this paper
• Characterization and biodistribution of recombinant and recombinant/chimeric constructs of monoclonal antibody B72.3.

  1989cites this paper
• Innovations in monoclonal antibody tumor targeting. Diagnostic and therapeutic implications.

  1989cites this paper
• Imaging of colorectal carcinoma with radiolabeled antibodies.

  1989cites this paper
• Diagnosis of ovarian cancer with radiolabelled monoclonal antibodies: our experience using 131I-B72.3.

  1989cites this paper
• Monoclonal Antibodies Raised Against Human Colon Carcinoma

  1989cites this paper
• Radioimmunodetection of a Local Recurrence of Rectal Carcinoma by 131I-labeled Anticarcinoembryonic Antigen Monoclonal Antibody AntiCEA 102

  1989cites this paper
• Differences in biodistribution of indium-111-and iodine-131-labeled B72.3 monoclonal antibodies in patients with colorectal cancer.

  1989cites this paper
• Immunoreactivity of tumor-associated glycoprotein (TAG-72) in normal, hyperplastic, and neoplastic colon.

  1989cites this paper
• Generation and characterization of B72.3 second generation monoclonal antibodies reactive with the tumor-associated glycoprotein 72 antigen.

  1988cites this paper
• Radioimmunolocalization of human carcinoma xenografts with B72.3 second generation monoclonal antibodies.

  1988cites this paper